Role of Brachytherapy in the Boost Management of Anal Carcinoma With Node Involvement (CORS-03 Study)
- 1 March 2013
- journal article
- research article
- Published by Elsevier BV in International Journal of Radiation Oncology*Biology*Physics
- Vol. 85 (3), e135-e142
- https://doi.org/10.1016/j.ijrobp.2012.09.034
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Anal Canal Cancer: Management of Inguinal Nodes and Benefit of Prophylactic Inguinal Irradiation (CORS-03 Study)International Journal of Radiation Oncology*Biology*Physics, 2012
- High-Dose Split-Course Radiation Therapy for Anal Cancer: Outcome Analysis Regarding the Boost Strategy (CORS-03 Study)International Journal of Radiation Oncology*Biology*Physics, 2011
- ACT II: The Second UK Phase III Anal Cancer TrialClinical Oncology, 2005
- The Evolving Treatment of Anal CancerArchives of Surgery, 2001
- The impact of gap duration on local control in anal canal carcinoma treated by split-course radiotherapy and concomitant chemotherapyInternational Journal of Radiation Oncology*Biology*Physics, 2001
- Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups.Journal of Clinical Oncology, 1997
- Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycinThe Lancet, 1996
- Effectiveness of combined radio-chemotherapy in the management of epidermoid carcinoma of the anal canalInternational Journal of Radiation Oncology*Biology*Physics, 1990
- Interstitial curietherapy in the conservative treatment of anal and rectal cancersInternational Journal of Radiation Oncology*Biology*Physics, 1989
- Combined therapy for cancer of the anal canalDiseases of the Colon & Rectum, 1974